Cargando…

Molecular Simulations and Drug Discovery of Adenosine Receptors

G protein-coupled receptors (GPCRs) represent the largest family of human membrane proteins. Four subtypes of adenosine receptors (ARs), the A(1)AR, A(2A)AR, A(2B)AR and A(3)AR, each with a unique pharmacological profile and distribution within the tissues in the human body, mediate many physiologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jinan, Bhattarai, Apurba, Do, Hung N., Akhter, Sana, Miao, Yinglong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000248/ https://www.ncbi.nlm.nih.gov/pubmed/35408454 http://dx.doi.org/10.3390/molecules27072054

Ejemplares similares

Binding Analysis Using Accelerated Molecular Dynamics Simulations and Future Perspectives
por: Pawnikar, Shristi, et al.
Publicado: (2022)

Pathways and Mechanism of Caffeine Binding to Human Adenosine A(2A) Receptor
por: Do, Hung N., et al.
Publicado: (2021)

Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A(1) Receptor
por: Miao, Yinglong, et al.
Publicado: (2018)

Challenges and frontiers of computational modelling of biomolecular recognition
por: Wang, Jinan, et al.
Publicado: (2022)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung N., et al.
Publicado: (2023)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung N., et al.
Publicado: (2023)

Deep Learning Dynamic Allostery of G-Protein-Coupled Receptors
por: Do, Hung, et al.
Publicado: (2023)

Mechanism of ligand recognition by human ACE2 receptor
por: Bhattarai, Apurba, et al.
Publicado: (2020)

Mechanism and Pathways of Inhibitor Binding to the Human ACE2 Receptor for SARS-CoV1/2
por: Bhattarai, Apurba, et al.
Publicado: (2021)

Effects of presenilin-1 familial Alzheimer’s disease mutations on γ-secretase activation for cleavage of amyloid precursor protein
por: Do, Hung N., et al.
Publicado: (2023)

Improved Modeling of Peptide-Protein Binding Through Global Docking and Accelerated Molecular Dynamics Simulations
por: Wang, Jinan, et al.
Publicado: (2019)

Deep Boosted Molecular Dynamics (DBMD): Accelerating molecular simulations with Gaussian boost potentials generated using probabilistic Bayesian deep neural network
por: Do, Hung N., et al.
Publicado: (2023)

Specific Engineered G Protein Coupling to Histamine Receptors Revealed from Cellular Assay Experiments and Accelerated Molecular Dynamics Simulations
por: Höring, Carina, et al.
Publicado: (2021)

Molecular dynamics simulations and drug discovery
por: Durrant, Jacob D, et al.
Publicado: (2011)

Mechanisms of γ-Secretase Activation and Substrate Processing
por: Bhattarai, Apurba, et al.
Publicado: (2020)

Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
por: Jacobson, Kenneth A., et al.
Publicado: (2020)

Structural basis of agonist specificity of α(1A)-adrenergic receptor
por: Su, Minfei, et al.
Publicado: (2023)

Efficient purification and assembly of ribonucleoprotein complex for interaction analysis by MST assay coupled with GaMD simulations
por: Gao, Yunrong, et al.
Publicado: (2021)

Recent Insights from Molecular Dynamics Simulations for G Protein-Coupled Receptor Drug Discovery
por: Zou, Ye, et al.
Publicado: (2019)

Adenosine, Adenosine Receptors and Neurohumoral Syncope: From Molecular Basis to Personalized Treatment
por: Guieu, Régis, et al.
Publicado: (2022)

Molecular probes for the human adenosine receptors
por: Yang, Xue, et al.
Publicado: (2020)

Structures of β(1)-adrenergic receptor in complex with Gs and ligands of different efficacies
por: Su, Minfei, et al.
Publicado: (2022)

Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation
por: Maille, Baptiste, et al.
Publicado: (2022)

The future of molecular dynamics simulations in drug discovery
por: Borhani, David W., et al.
Publicado: (2011)

Molecular Modeling of Histamine Receptors—Recent Advances in Drug Discovery
por: Mehta, Pakhuri, et al.
Publicado: (2021)

Adenosine and adenosine receptor-mediated action in coronary microcirculation
por: Zhang, Ying, et al.
Publicado: (2021)

Adenosine and adenosine receptors: Newer therapeutic perspective
por: Manjunath, S., et al.
Publicado: (2009)

Adenosine Receptors and Wound Healing
por: Cronstein, Bruce N.
Publicado: (2004)

In Silico Drug Design for Purinergic GPCRs: Overview on Molecular Dynamics Applied to Adenosine and P2Y Receptors
por: Salmaso, Veronica, et al.
Publicado: (2020)

Progress in the discovery of selective, high affinity A(2B) adenosine receptor antagonists as clinical candidates
por: Kalla, Rao V., et al.
Publicado: (2008)

Cancer biology and molecular genetics of A(3) adenosine receptor
por: Mazziotta, Chiara, et al.
Publicado: (2021)

Structure-Based Discovery of A(2A) Adenosine Receptor Ligands
por: Carlsson, Jens, et al.
Publicado: (2010)

Adenosine deaminase activity modulation by some street drug: molecular docking simulation and experimental investigation
por: Amanlou, Massoud, et al.
Publicado: (2014)

Internalization and desensitization of adenosine receptors
por: Klaasse, Elisabeth C., et al.
Publicado: (2007)

Allosteric modulation of adenosine receptors
por: Göblyös, Anikó, et al.
Publicado: (2008)

Chemical Probes for the Adenosine Receptors
por: Federico, Stephanie, et al.
Publicado: (2019)

Applying high-performance computing in drug discovery and molecular simulation
por: Liu, Tingting, et al.
Publicado: (2016)

Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data
por: Fishman, Pnina
Publicado: (2022)

Systems Pharmacology in Small Molecular Drug Discovery
por: Zhou, Wei, et al.
Publicado: (2016)

Adenosine receptor signalling in Alzheimer’s disease
por: Trinh, Phuc N. H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u35enk1tnus973k08jhm05990v